Patients
19.5 %
Early deaths from long-term diseases, Malaysia, 2023 (WHO).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Chandani Patel
Malaysia Heart Failure Devices Market Industry Trends and Forecast to 2034: Segmented by (Device, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$20.9 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $18.7 Mn | — | — |
| 2025 (base) | $20.3 Mn | +$1.5 Mn | — |
| 2026 (forecast) | $21.9 Mn | +$1.7 Mn | +8.2% |
| 2027 (forecast) | $23.7 Mn | +$1.8 Mn | +17.1% |
| 2028 (forecast) | $25.7 Mn | +$1.9 Mn | +26.7% |
| 2029 (forecast) | $27.8 Mn | +$2.1 Mn | +37.1% |
| 2030 (forecast) | $30.0 Mn | +$2.3 Mn | +48.3% |
| 2031 (forecast) | $32.5 Mn | +$2.5 Mn | +60.5% |
| 2032 (forecast) | $35.2 Mn | +$2.7 Mn | +73.6% |
| 2033 (forecast) | $38.0 Mn | +$2.9 Mn | +87.9% |
| 2034 (forecast) | $41.2 Mn | +$3.1 Mn | +103.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $20.3 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $41.2 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 8.2% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Device, use and end user (see all) |
| Key players | Abbott Laboratories, Medtronic, Boston Scientific Corporation, Abiomed (Johnson & Johnson), Impulse Dynamics (see all) |
| Regulator in Malaysia | MDASource: Medical Device Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Heart failure devices help weak hearts pump or keep rhythm, including pumps, defibrillators, resynchronisation devices and sensors.
Key segments of the heart Failure Devices market include device (Ventricular Assist Devices, CRT Devices and ICDs) and use (Bridge to Transplant, Destination Therapy and Monitoring).
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the heart Failure Devices market.
Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the heart Failure Devices market room to grow.
High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the heart Failure Devices market.
The heart Failure Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices must be registered with the Medical Device Authority (MDA) under the Medical Device Act 2012.[1] Public clinics and hospitals run by the Ministry of Health give heavily subsidised care.[2] Early deaths from long-term diseases: 19.5% in 2023, the latest WHO figure for Malaysia.[3]
[1] Medical Device Authority. Checked 14 Nov 2026.
[2] Ministry of Health Malaysia. Checked 14 Nov 2026.
[3] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how heart Failure Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Malaysia.
What doctors and scientists are doing in Heart Failure Devices right now, from free public sources.
19.5 %
Early deaths from long-term diseases, Malaysia, 2023 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 16 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.
From our blog
Malaysia · 1 shared keyword
Malaysia · 1 shared keyword
Malaysia
Malaysia
Malaysia
Malaysia
Digital Health · Malaysia
Pharmaceuticals · Malaysia
Pharmaceuticals · Malaysia
Pharmaceuticals · Malaysia
Pharmaceuticals · Malaysia
Healthcare Services · Malaysia